Currently, the United States is experiencing a shortage of penicillin G benthazine, the recommended treatment for syphillis and the only recommended treatment for pregnant women infected or exposed to syphilis. Pfizer, the sole manufacturer or Bicillin L-A (brand name for penicillin G) in the US, is experiencing a manufacturing delay and is working with the Center for Disease Control and Prevention (CDC) Division of STD Prevention (DSTDP) and the Food and Drug Administration (FDA) to resolve this situation. As a result of the shortage, I am asking that you notify the District of Columbia Department of Health of your inventory so that we can monitor supply in the District.